The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...

根据诺和诺德官网管线资料，该公司拟开发这款GIP/GLP-1受体激动剂用于2型糖尿病和减重。根据ClinicalTrials官网，诺和诺德此前已经在美国、日本、澳大利亚、韩国等地已经启动了NNC0519-0130注射液的多项1期和2期临床研究，计划评 ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

拉斯克奖颁奖语提到，全球有近9亿成年人患有肥胖症。体重过重是多种危及生命的疾病的根源。肥胖通常被视为意志力的失败，但对许多人来说，节食和锻炼并不能治愈肥胖问题。从历史上看，制造安全有效的减肥药物的尝试都失败了。哈本纳、莫伊索夫和克努森开创了体重管理的 ...

This week, a letter surfaced in which Eli Lilly asked for a patient to release medical information so it could contact her ...

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) ...

We don't know how a caloric deficit caused by taking a GLP-1 would alter that development," said Dr. Brian Erly ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Ozempic is a medication for Type 2 diabetes that helps control blood sugar, with the added side effect of weight loss.

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...